PortView
Loncar Cancer Immunotherapy (CNCR) ETF Holdings & Analysis
ETFOther
What CNCR does
This exchange-traded fund tracks an index primarily consisting of common stock from roughly 30 pharmaceutical or biotechnology companies. These firms are handpicked by the index provider due to their strong emphasis on creating innovative drugs that harness the human body's natural immune defenses to combat cancer. The fund's advisor aims to allocate all, or nearly all, of its capital into the underlying securities and American Depositary Receipts (ADRs) that comprise this benchmark index. A minimum of 80% of the fund's overall holdings will consistently be directed towards these specific index components. Notably, this fund operates as a non-diversified investment vehicle.
Fund profile
Top holdings
| Holding | Weight | |
|---|---|---|
| Instil Bio, Inc. | 3.59% | |
| Replimune Group, Inc. | 3.54% | |
| Iovance Biotherapeutics, Inc. | 3.47% | |
| Zymeworks Inc. | 3.45% | |
| argenx SE | 3.42% | |
| Genmab A/S | 3.42% | |
| CRISPR Therapeutics AG | 3.39% | |
| AstraZeneca PLC | 3.39% | |
| Bristol-Myers Squibb Company | 3.39% | |
| Merck & Co., Inc. | 3.37% |
Sector allocation
| Cash & Others | 0.13% |
| Financial Services | 3.29% |
| Healthcare | 96.58% |
Geographic allocation
| United States | 86.25% |
| Netherlands | 3.42% |
| Denmark | 3.42% |
| United Kingdom | 3.39% |
| Switzerland | 3.39% |
| Other | 0.13% |
PortView Portfolio Insights
PortView analyzes how CNCR fits your actual portfolio — position weight, ETF overlap with your other funds, sector and geographic exposure, concentration, and how this fund contributes to your portfolio risk and return. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze CNCR in PortView →Related securities
Related stocks
Frequently asked questions
- What does CNCR track?
- CNCR is the Loncar Cancer Immunotherapy ETF, a Other ETF.
- What is the expense ratio of CNCR?
- Expense ratio data for CNCR is shown on the page when available from our data provider.
- What are the largest holdings in CNCR?
- Top holdings include TIL, REPL, IOVA, ZYME, ARGX.
- How can PortView analyze CNCR overlap with other ETFs?
- PortView computes the holdings overlap between CNCR and the other ETFs and stocks you own, plus your combined sector and geographic exposure, so you can see true diversification.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.